All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Risk

Risk

In multiple myeloma, some specific factors are linked to survival, such as extramedullary disease, quality of therapy response, disease stage, time of relapse after transplant, detection of specific chromosomal aberrations, or level of circulating plasma cells. Within this section, new factors contributing to disease prognosis will be added, such as infection with COVID-19.
|||